EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Audiological Outcomes of Salvage Intratympanic Corticosteroid Therapy in Idiopathic Sudden Sensorineural Hearing Loss

Carina Götting, Claudia Lädrach, Sara-Lynn Hool, Samuel Tschopp, Marco Caversaccio, Urs Borner, Lukas Anschuetz

Audiology and Neurotology · 31.03.2026 · 31 (4) · 282-290

DOI: 10.1159/000551750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Audiology and Neurotology, online erschienen am 31.03.2026. Verfasst von Carina Götting und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, carina.goettin…. Hauptthemen laut MEDLINE: Hearing Loss, Sensorineural, Hearing Loss, Sudden, Dexamethasone, Salvage Therapy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Intratympanic corticosteroids (ITCs) are used to treat patients with idiopathic sudden sensorineural hearing loss (ISSNHL) when systemic therapy has been unsuccessful. However, the efficacy of this treatment remains uncertain.

Methods

We retrospectively analysed ISSNHL patients at a tertiary reference centre, who received ITC injections following unsuccessful systemic corticosteroid therapy administered either orally or intravenously. Patients were eligible for ITC if they showed insufficient improvement after systemic treatment, defined as a remaining hearing loss of ≥30 dB HL in at least three frequencies. They received three intratympanic injections of 0.3–0.5 mL dexamethasone (4 mg/mL) within 10–14 days from first to last injection. Changes in pure-tone audiometry were assessed.

Results

A total of 34 patients met the inclusion criteria for the study. The mean pure tone average (PTA) improvement was 10.62 dB HL. A total of 18 (53%) patients showed hearing improvement of ≥10 dB HL (of these: n = 11 (32%) ≥20 dB HL, n = 2 (6%) ≥30 dB HL). Sixteen (47%) patients had an improvement of less than 10 dB HL. In addition to the PTA analysis, individual frequencies at 0.5 kHz, 1 kHz, 2 kHz, and 4 kHz were examined and showed significant improvements, with p values ranging from 0.007 to 0.037. Regarding the World Health Organization grading of hearing impairment, 13 (38.2%) patients improved by at least one category. Concomitant vestibular syndrome (n = 5) showed a marginally non-significant trend (p = 0.066) towards less improvement. There was no significant correlation between age and degree of hearing loss (p = 0.123). Complications of ITC were minimal, with only 1 patient reporting a temporary headache following injection.

Conclusion

In patients with persistent ISSNHL after systemic corticosteroid therapy, ITC injections resulted in limited hearing improvement. Despite the low risks associated with this therapy, its routine use should be considered on a case-by-case evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing Loss, SensorineuralHearing Loss, SuddenDexamethasoneSalvage TherapyGlucocorticoidsHumansFemaleMiddle AgedRetrospective StudiesMaleInjection, IntratympanicAudiometry, Pure-ToneAdultTreatment OutcomeAgedAuditory AcuityYoung Adult

Stichwörter der Autor:innen

Idiopathic sudden sensorineural hearing lossIntratympanic corticosteroid injectionSalvage treatment

Substanzen

DexamethasoneGlucocorticoids

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, carina.goetting@students.unibe.ch.
  • Department of Otolaryngology-Head and Neck Surgery, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Otorhinolaryngology-Head and Neck Surgery, CHUV, University of Lausanne, Lausanne, Switzerland.
  • The Sense Research and Innovation Center, Lausanne, Switzerland.

Zitieren

APA

Götting, C., Lädrach, C., Hool, S. L., Tschopp, S., Caversaccio, M., Borner, U., & Anschuetz, L. (2026). Audiological Outcomes of Salvage Intratympanic Corticosteroid Therapy in Idiopathic Sudden Sensorineural Hearing Loss. Audiology and Neurotology, 31(4), 282-290. https://doi.org/10.1159/000551750

Vancouver

Götting C, Lädrach C, Hool SL, Tschopp S, Caversaccio M, Borner U, et al. Audiological Outcomes of Salvage Intratympanic Corticosteroid Therapy in Idiopathic Sudden Sensorineural Hearing Loss. Audiology and Neurotology. 2026;31(4):282-290. doi:10.1159/000551750

BibTeX
@article{Gtting2026,
  author = {Götting, Carina and Lädrach, Claudia and Hool, Sara-Lynn and Tschopp, Samuel and Caversaccio, Marco and Borner, Urs and Anschuetz, Lukas},
  title = {Audiological Outcomes of Salvage Intratympanic Corticosteroid Therapy in Idiopathic Sudden Sensorineural Hearing Loss},
  journal = {Audiology and Neurotology},
  year = {2026},
  volume = {31},
  number = {4},
  pages = {282--290},
  doi = {10.1159/000551750}
}
Kostenlos starten →